A Melbourne professor has helped lead new research using a gene therapy to regenerate damaged optic nerve fibres, in a discovery that could determine future glaucoma treatments. Read more
Atropine dose comparison shows a clear winner for myopia control
A concentration of 0.05% atropine slowed the rate of myopia progression in pre-teen children compared with two other concentrations of the drug, according to findings published in Ophthalmology. Read more
Cornea resistant to the novel coronavirus – study
A new study has suggested the cornea can resist infection from the novel coronavirus, in findings that bode well for corneal transplants and similar procedures. Read more
Changing visual behaviour of 2020 revealed in new survey
Half of the Australian population is experiencing negative impacts to their eyesight due to rapidly changing lifestyles in 2020, according to new research from Zeiss. Read more
Aussie-developed glaucoma implant performs well in initial trial
A Victorian biopharmaceutical company has reported positive results from a Phase 1 study examining the safety of its biodegradable implant for glaucoma. Read more
New group focuses on how to clear the COVID-19 backlog
The Centre for Eye Research Australia (CERA) has established a new research unit to improve current eyecare models and tackle the backlog of undiagnosed and untreated conditions brought on by the COVID-19 pandemic. Read more
More than half of Aussies unaware the sun causes permanent eye damage
New research commissioned by a major optometry provider has found 60% of Australians aren’t aware the sun can cause permanent eye damage through conditions such as cataracts, cancer or macular degeneration. Read more
New Specsavers website shares eye health data insights
Specsavers has launched its new HealthHub website to share updates on detection, referral and treatment progress for key eye conditions, as well as the use of optometry services in New Zealand and Australia. Read more
Quinlivan grant goes beyond ‘how and why’ of glaucoma research
An optometrist-turned-research fellow leading a world-first clinical trial investigating whether daily doses of vitamin B3 could prevent glaucoma blindness has been awarded Glaucoma Australia (GA)’s 2020 Quinlivan Research Grant. Read more
Macular disease funding bequest opens doors for blue sky thinking
A new stream of funding for ‘blue sky’ macular disease research is now available for early-career researchers after a woman who cared for her visually impaired father bequeathed a major sum to the Macular Disease Foundation Australia (MDFA). Read more